Biolife Solutions Target Price

Biolife Solutions posts a target price of $31. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $31 for BLFS means covering analysts, on average, see the stock 12.1% downside of $35.25 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for BLFS's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Biolife Solutions's other metric pages and overview cover the third.

Judging Biolife Solutions against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $31 here, then scan peer and history charts to see if the gap is persistent.